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 INTRODUCTION
 Screening for colorectal cancer (CRC) has been proven as an 
eff ective prevention strategy to reduce CRC incidence and 
mortality ( 1 ). Many international guidelines recommended CRC 
screening by fl exible sigmoidoscopy (FS) on a 5-yearly basis, and 
colonoscopy were performed 10 yearly ( 2–4 ). FS has been demon-
strated to reduce CRC mortality by randomized controlled 
trials and systematic reviews. In relatively resource-deprived 
countries where colonoscopic capacity may be limited, FS bears 
potential as a primary screening test as it can be performed by 
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primary care practitioners ( 2 ). FS-based screening could exam-
ine neoplastic lesions in the distal colorectum. Any distal lesions 
detected could indicate synchronous risk of proximal neoplasia 
(PN) and advanced proximal neoplasia (APN). According to the 
latest US Preventive Services Task Force Recommendation State-
ments published in 2016 ( 5,6 ), FS is one of the preferred tests of 
choice designed both to detect and prevent CRC if colonoscopy is 
not available or acceptable to patients.
 Understanding the association between distal and proximal 
fi ndings is clinically important, as it guides subsequent follow-
up for subjects with distal lesions found on FS. In four published 
meta-analyses ( 7–10 ), the relationship between distal hyperplastic 
polyp (HP) and PN/APN in asymptomatic population presented 
mixed conclusions. Dave  et al. ( 7 ) proposed that, for asymptomatic 
subjects, any distal HP detected by FS should be referred for colo-
noscopy workup due to an excessive 20–25% risk of any PN and 
4–5% risk of APN. Th is conclusion was later challenged by fi nd-
ings from two meta-analyses ( 8,9 ) that found no excessive risk of 
PN or APN conferred by the presence of distal HPs. However, the 
latest meta-analysis performed in 2012 that examined the relation-
ship between distal lesions and PN/APN ( 10 ) concluded that all 
types of distal lesions, including HPs, were predictive of PN while 
all types of distal neoplasia were predictive of APN. Among these 
four meta-analyses, nevertheless, three were published more than 
a decade ago; and in the latest study published in 2012, approxi-
mately one-third of all the articles (12 in 40) selected were from 
symptomatic subjects, and hence its generalizability to guide CRC 
screening among asymptomatic subjects was limited. In addition, 
since year 2012, several studies with large sample size ( 11–16 ) were 
published and many of them were from population-based screen-
ing programs ( 13–15 ). Th ese additional studies allow re-synthesis 
of existing data to evaluate the association between distal and 
proximal lesions.
 Th e purpose of this systematic review and meta-analysis is to 
analyze all available data on the risk of PN and APN in asympto-
matic subjects who were detected as having distal lesions with dif-
ferent types of histopathology. In particular, we tested the  a priori 
hypothesis that distal HP was not associated with PN in asympto-
matic screening populations, aiming to inform necessity of subse-
quent colonoscopy workup for individuals with distal HP detected 
by FS.
 METHODS
 Search strategy and selection criteria
 Th e systematic review and meta-analysis adhered to the PRISMA 
(Preferred Reporting Items for Systematic reviews and meta-
Analyses) statement ( 17 ), performed according to a predeter-
mined protocol. We searched Ovid Medline (1946 to 30 June 
2016), EMBASE (1976 to 30 June 2016), and the Cochrane 
Library (1988 to 31 May 2016). Th e search strategy was listed as 
below:
 1 .  Rectal Neoplasms/or Colorectal Neoplasms/or Colonic 
Polyps/or Colonic Neoplasms/ 
 2 .  (((colon* or rectal or colorectal) adj (cancer* or neoplas* or 
tumor* or tumour* or carcinoma* or sarcoma* or adenom* 
or adeno?carcinoma* or lesion* or polyp*)) or CRC).ti,ab. 
 3 .  ((proximal or right-side* or “right side*”) adj2 (neoplas* or 
lesion* or tumor* or tumour* or polyp*)).mp. 
 4 .  ((distal or left -side* or “left  side*”) adj2 (neoplas* or lesion* 
or tumor* or tumour* or polyp*)).mp. 
 5 .  case control studies/ or cohort studies/or cross-sectional 
studies 
 6 .  ((cohort adj (study or studies)) or “case control” or “cohort 
analy*” or (observational adj (study or studies)) or longitudi-
nal or retrospective or “cross sectional” or cross-sectional or 
(follow up adj (study or studies))).mp. 
 7 .  1 or 2 
 8 .  5 or 6 
 9 .  3 and 4 
 10 .  7 and 8 
 11 .  9 and 10 
 We restricted our search to cross-sectional studies, case control 
studies, and prospective cohort studies on CRC screening that 
examined the relationship between distal fi ndings of various 
histopathology and PN/APN for average-risk, asymptomatic 
subjects. Th e following types of studies were excluded:
 1 .  Studies that recruited symptomatic patients ( 18,19 ); 
 2 .  Studies that did not examine the association between distal 
and proximal fi ndings ( 20 ); 
 3 .  Studies without data on PN or APN ( 21,22 ); 
 4 .  Studies where the screening participants had high risk for 
CRC, such as those with positive family history ( 23 ); 
 5 .  Studies that consist of data on proximal advanced serrated 
lesions only ( 24 ). 
 We obtained data from summary estimates of all eligible studies 
without any language limitations. Reference lists of eligible studies 
and related meta-analyses were hand searched to identify further 
relevant studies.
 Data analysis
 Two reviewers (J.L.W.H., Y.H.W.) independently screened all 
abstracts identifi ed in the initial search and excluded studies 
not fulfi lling the eligible criteria. Th ey extracted data from all 
selected full-text articles reviewed in duplicate, and in cases of 
disagreement, consensus was made via referral to a third reviewer 
(M.C.S.W.). Th e following variables were collected from each 
study: sample size, mean age of study participants, proportion 
of male subjects, research type (cross-sectional, case control, or 
cohort studies), endoscopic strategies (colonoscopy; sigmoido-
scopy followed by colonoscopy, if necessary), and program design 
(population-based or opportunistic screening), as well as endo-
scopy quality-control measures (critical or normal).
 In these studies, the odds ratio (OR) and absolute risk for PN 
or APN conferred by distal HP, distal adenoma (AD), or distal 
advanced neoplasia (AN), when compared with subjects with 
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normal distal fi ndings, were retrieved. Th e proportions of individu-
als with PN and APN in all eligible studies were also examined. Th e 
proportions of PN and APN were fi rst synthesized and then exam-
ined in four types of subjects with various distal fi ndings: normal, 
HP, AD, and AN. AN was defi ned as adenomas measuring ≥10 cm, 
adenomas with villous portions, high-grade dysplasia, adenocar-
cinomas, or any combination thereof ( 20 ). If multiple lesions were 
reported in one subject, we used the most advanced distal or proxi-
mal lesion as the fi nding. Th e primary outcomes included the ORs 
and proportion of PN or APN among the subgroups of HP, AD, 
or AN, as well as the respective 95% confi dence interval (CI). Th e 
Mantel–Haenszel method based on a random-eff ects model was 
used. We tested for heterogeneity by calculating  P value and the  I 2 
statistic in a standard manner, where  I 2 >50% or  P <0.05 was consid-
ered as a threshold indicating signifi cant heterogeneity.
 We used the statistical analysis soft ware (Revman 5.3, Copenhagen, 
Denmark: Th e Nordic Cochrane Centre, Th e Cochrane Collabora-
tion, 2014) to synthesize the pooled estimation of OR and perform 
subgroup analysis. We explored potential publication bias with an 
inverted funnel plot analysis with Eggers’ regression model by Com-
prehensive Meta Analysis (version 2.2, Biostat, 2011, Englewood, NJ).
 Subgroup analysis
 We conducted a comprehensive quality assessment for all 
selected studies during our review process. Because our selected 
articles are observational studies, we employed the Newcastle 
Ottawa Scale for cross-sectional studies ( 25 ) to evaluate the 
selection, comparability, and outcome among the studies. We 
renamed the index according to the above identifi ed variables. 
Studies that reported compliance with endoscopic quality-con-
trol protocols were scored 2 while studies that did not report 
endoscopic quality were scored 1. If there were no descriptions 
of the endoscopic tests, a zero score was assigned. For pathol-
ogy reporting of colorectal fi ndings, we assigned a score of 2 for 
blind reporting with universal pathological standard; a score of 1 
for simple description of the reporting process, and 0 for studies 
giving no details. For subject selection, those studies collect-
ing data based on population registries, enrolling subjects from 
predefi ned protocols, or GP rosters were given 1 point; while 
recruitment of patients from special populations or physician 
referral were given zero points, owing to the limited representa-
tiveness of the target population. Because the average sample 
size of our selected studies were >3,000, we named studies with 
>3,000 subjects as large population (score=1), and studies with 
sample size <3,000 as small population (score=0). Regarding sta-
tistical tests, if the tests used to analyze the data were described 
clearly and judged appropriately, and the measurement of the 
association was presented, including CIs and the probability 
level ( P value), 1 point was given; otherwise, a zero point was 
assigned. If there was a control variable for APN in the study, 
Records identified through
database searching (n=235)
121 from Embase, 108 from
Ovid Medline, 6 from Cochrane
Additional records identified
through other sources (n=21)
including 1 unpublished study
Records after duplicates were removed (n=74)
Records screened
(n=182)
Full-text articles assessed
for eligibility
(n=72)
Studies included in
meta-analysis
(n=28)
Records excluded (n=110):
Irrelevant studies (n=72), other
colorectal diseases (n=30), review
articles (n=8)
Full-text articles excluded (n=44):
Symptomatic subjects/ high-risk individuals
(n=22), no data for PN or APN (n=12),
studies without relationship between distal
findings and PN (n=7), studies on
polypectomy/serrated lesion (n=3)
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 Figure 1 .  Results of the literature search. APN, advanced proximal neoplasia; PN, proximal neoplasia.
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reported that distal HP had higher odds of PN and APN, when 
compared with individuals with normal distal fi ndings. Subjects 
with distal AD had signifi cantly higher odds of PN (OR=2.36, 95% 
CI 1·91–2·92) and APN (OR=2·52, 95% CI 1·84–3·46) compared 
with subjects with normal distal fi ndings. Th ese increased odds 
could also be observed in subjects with distal AN. It was found 
that the more advanced the distal lesions, the higher the odds of 
PN/APN. Th ere was no signifi cant heterogeneity when the asso-
ciations between distal HP and PN ( I 2 =40%,  P =0.28)/APN ( I 2 =5%, 
 P =0.39) were examined ( Figure 3a,b ).
 Table 4 shows subgroup analyses according to study character-
istics that were regarded as potential moderators of the association 
between distal fi ndings and PN/APN. Weaker associations were 
noticed in high-quality studies than in low-quality ones (AN-PN); 
in studies with large sample size than those with small sample size 
(AD-PN); in studies based on population-based design than those 
based on opportunistic screening approaches (AN-PN, AD-APN, 
AN-APN, HP-APN); in studies with critical endoscopy qual-
ity control than in studies with normal quality-control measures 
(AN-PN, AN-APN); in studies where distal lesions were defi ned as 
those located in rectosigmoid vs. studies where distal lesions were 
defi ned as those distal to the splenic fl exure (AD-APN, AN-APN); 
in studies where FS was performed followed by colonoscopy as a 
separate procedure than in studies where only colonoscopy was 
performed (HP-PN, AD-PN, AD-APN, AN-PN, AN-APN).  Sup-
plementary Figure S1 illustrates the Egger’s regression tests for 
publication bias. Except for distal AN-APN, all regression tests 
had  P values >0.05. Th e pooled prevalence of isolated PN (5.6%, 
95% CI 3.3–9.1%) and isolated APN (1.0%, 95% CI 0.9–1.2%) are 
shown in  Supplementary Figure S2 ). Th e proportion of APN was 
1.9% (95% CI 1.5–2.5%) among subjects with normal distal fi nd-
ings and 2.4% (95% CI 1.9–3.1%) among subjects with distal HPs 
( P =0.390).
 DISCUSSION
 Th is study found that distal HP was not associated with higher 
odds of APN or PN. Th e fi ndings were robust from subgroup 
analyses with no publication biases detected. On the contrary, the 
presence of distal AN or AD were signifi cantly associated with 
APN/PN. Whether to refer subjects with distal HP detected by 
FS for colonoscopy workup has been the subject of a long-lasting 
debate beginning in the 1980s–1990s, leading to three meta-anal-
yses performed in the early 2000s. Th e study by Lin  et al. ( 9 ) was 
the only evaluation that performed subgroup analysis stratifying 
21 studies into screening and diagnostic cohorts. It was concluded 
that there was no increased risk of PN and APN in subjects with 
distal HP when compared with those having normal distal fi nd-
ings, based on observations in asymptomatic screening individu-
als. Two meta-analyses ( 7,8 ) reported that in screening studies the 
relative risk of distal HP for PN (1.3, 95% CI 0.9–1.8), the OR of 
distal HP for PN (1·44, 95% CI 0.79–2.62), and the OR of distal 
HP for APN (1.63, 95% CI 0.61–4.33) were not statistically sig-
nifi cant, yet a recent meta-analysis found that HP was a predictor 
for PN (OR=1.8, 95% CI 1.3–2.5) ( 10 ). Our study is consistent 
one extra mark was given. Th us there was a maximum of eight 
points for Newcastle Ottawa Scale assessment in this study. 
Again, two authors assessed all the selected studies separately 
and sought consensus for any disagreements through referral to 
the third reviewer.
 Th e data were expected to be heterogeneous. Seven subgroup 
analyses on the risk of PN and APN were conducted according to 
the study characteristics: (1) study quality: high-quality score (4–8) 
vs. low-quality score (1–3); (2) sample size:  n >3000 vs.  n ≤3000; 
(3) program design: population-based vs. opportunistic screening; 
(4) endoscopy quality control: normal procedures vs. high-level 
quality control; (5) the inclusion of serrated lesion in the defi ni-
tion of AN vs. not; (6) the defi nition of distal lesions: based on 
the splenic fl exure as the demarcation point vs. the rectosigmoid; 
and (7) the procedure of examination: FS followed by a subsequent 
colonoscopy as a separate procedure vs. colonoscopy only. Th ese 
subgroup analyses are important as we perceived them as potential 
eff ect modifi ers of the present meta-analyses.
 RESULTS
 A total of 235 titles were obtained from the three databases 
( Figure 1 ), in addition to another 21 titles from previous system-
atic reviews and 1 unpublished study performed by our research 
group) ( 47 ). Aft er excluding 74 duplicates, 182 abstracts were 
reviewed. Among them, 110 articles were excluded based on the 
selection criteria. Aft er reviewing 72 full texts, 44 studies were 
found ineligible. Twenty-eight studies were fi nally included in the 
meta-analysis with a total of 104,961 subjects ( Table 1 ), and the 
adenoma detection rate ranged from 2.9% to 48.1%. Th e major-
ity of selected studies that employed a population-based design in 
recruiting subjects were of high quality and used large sample size 
that were published aft er 2010 ( Table 2 ).
 From available data among the selected studies, the proportion 
of PN was 13.2% (95% CI, 10.7–16.1%) and that for APN was 
2.2% (95% CI, 1.7–2.8%) ( Figure 2a,b ).  Table 3 shows the pooled 
proportion and OR for the association between distal lesions and 
PN/APN. Among asymptomatic subjects, neither PN (OR=1.16, 
95% CI 0.89–1.51,  P =0.14,  I 2 =40%) nor APN (OR=1.09, 95% CI 
0.87–1.36,  P =0.39,  I 2 =5%) was associated with distal HP when 
compared with those having normal distal colon. Very few studies 
 Table 2 .  Studies characteristics in different decades 
 Year range of publication  1990–1999  2000–2009  2010–2016 
 Studies with large sample 
size a (%,  n / N ) 
 0 (0/3)  43.8 (7/16)  88.9 (8/9) 
 High-quality studies b 
(%,  n / N ) 
 33.3 (1/3)  62.5 (10/16)  88.9 (8/9) 
 Population-based studies 
(%,  n / N ) 
 0 (0/3)  6.3 (1/16)  33.3 (3/9) 
 a Studies with large sample size:  n >3000. 
 b High-quality study: Newcastle Ottawa Scale 4–7. 
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with the fi ndings by Lin  et al. ( 9 ), demonstrating no increased 
risk of PN/APN for distal HP when compared with subjects who 
had normal distal fi ndings. Our results imply that subjects with 
distal HP detected by FS should not be automatically referred for 
subsequent colonoscopy workup. Yet the fi ndings of the present 
study should be interpreted with caution, as there is still a risk of 
PN/APN in subjects with normal distal colon or distal HPs—and 
proximal lesions could only be detected by colonoscopy. Th is is 
refl ected by the pooled prevalence of isolated PN (5.6%) and iso-
lated APN (1.0%), which could be regarded by some as signifi cant 
and should be taken into account when one considers arrange-
ment of follow-up colonoscopy.
 Association studies between distal lesions and PN are impor-
tant, given FS can only visualize the distal colon. Th e meta-analysis 
performed by Dodou and De Winter ( 10 ) found that the higher the 
histological grade of the distal fi nding, the higher the risk for both 
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discriminatory than relying on FS result alone to risk-stratify sub-
jects for colonoscopy in current practice protocols, because of 
their limited performance to predict APN ( 13,15 ). Th e results of 
the present study are applicable to subjects who have undergone 
FS screening, where distal fi ndings are available as a predictor for 
PN/APN.
 For CRC screening, opportunistic testing for individuals is now 
shift ing toward organized population screening program with 
high quality-control measures and regular surveillance intervals. 
Screening based on population-based design could be more repre-
sentative of real-life practices in organized government programs, 
and the ORs of diff erent distal fi ndings to APN and PN in asymp-
tomatic individuals retrieved from studies in such programs might 
be more generalizable. On the contrary, opportunistic recruitment 
of asymptomatic subjects who received colonoscopy might include 
subjects with more diverse risk profi le ( 39 ). Th erefore, stronger 
associations between distal fi ndings and APN were observed in 
opportunistic screening design with higher degrees of heterogene-
ity. Th e OR for AN-APN and AN-PN in studies that adopted pop-
ulation-based designs could be more representative of real clinical 
practice. Endoscopy quality, among all quality-control measures to 
ensure high-quality CRC screening programs, is another impor-
tant eff ect modifi er. It is noticed that the OR of distal AN for 
APN in the studies with less stringent endoscopy quality control 
were higher than that in studies with more stringent quality-con-
trol procedures. Th e explanation of these fi ndings remains to be 
explored in future studies.
 When serrated lesions were included in the defi nition of AN, it 
was observed that the magnitude of the OR was higher; the dif-
ference was, however, not statistically signifi cant as there were 
only two studies that included serrated lesions. A previous study 
that examined a large cohort of Chinese screening participants 
found that the presence of large and proximal serrated polyps was 
an independent risk factor for synchronous advanced colorectal 
PN and APN. Our study presented a similar result, with relatively 
lower ORs. Th e major diff erence in the fi ndings between this study 
and the meta-analysis by Dodou and De Winter ( 10 ) in 2012 could 
be attributed to a number of diff erences in study design. First, we 
have included studies that exclusively examined asymptomatic 
individuals as CRC screening participants. In addition, our meta-
analysis included a much larger number of individuals, consisting 
of seven additional studies that were published aft er 2011–2012 
( 11–16,46 ), and one study performed in China with original data 
derived from high-quality colonoscopy procedures. Also, this 
meta-analysis has focused on the general screening population 
and excluded studies that evaluated the association between dis-
tal and proximal lesions among high-risk individuals that could 
potentially infl uence the magnitude of associations.
 Proximal shift  of CRC and increasing isolated PN have been 
reported in recent decades ( 10,48,49 ). Nevertheless, identifi cation 
of the association between the distal and proximal colon is particu-
larly valuable in countries where colonoscopic capacity might be 
limited. Th is is especially the case as FS is increasingly used in some 
countries, including several European nations ( 50 ). Th e prediction 
for PN and APN is crucial not only for allocation of colonoscopy 
resource in population-based screening programs but also for tai-
loring screening option to reduce avoidable procedures, minimize 
unnecessary complications, and reducing health-care cost. A few 
prediction models for APN have been devised and validated ( 51 ); 
however, those models usually required many variables, and their 
discriminatory capability was fair. Several studies employed distal 
fi nding as predictors in their risk algorithms for APN ( 12,31 ). For 
instance, Imperiale  et al. ( 31 ) included age, gender, and distal fi nd-
ing as predictors—and the model achieved good internal valida-
tion ( c -statistics=0.74) with high discrimination. Park  et al. ( 12 ) 
employed age, gender, smoking status, and distal fi nding detected 
by FS as predictive factors in an APN risk model for colonoscopy 
referral among low-risk subjects. Th is strategy might be more 
 Table 3 .  Proportion and OR of PN/APN among subjects of different distal fi ndings (random effects) 
 Proximal fi nding  Distal fi nding  N a  AR (95%CI) b  OR (95%CI) b  P  value c  I 2  (%) 
 PN  Normal  10  15.2 (14.8–15.7)  —   
  HP  6 (1)  14.9 (13.6–16.2)  1.16 (0.89–1.51)  0.14  40 
  AD  10 (10)  26.8 (25.7–27.9)  2.36 (1.91–2.92)  <0.001  79 
  AN  7 (7)  27.2 (25.7–28.7)  2.92 (2.06–4.15)  0.006  67 
 APN  Normal  13  1.9 (1.5–2.5)  —   
  HP  13 (1)  2.4 (1.9–3.1)  1.09 (0.87–1.36)  0.39  5 
  AD  18 (11)  3.9 (3.5–4.3)  2.52 (1.84–3.46)  <0.001  76 
  AN  19 (17)  10.4 (9.6–11.3)  5.70 (3.93–8.28)  <0.001  74 
 AD, adenoma; AN, advanced neoplasia; APN, advanced neoplasia; AR, absolute risk; CI, confi dential interval; HP, hyperplastic polyp, OR, odds ratio; PN, proximal 
neoplasia. 
 a Numbers in bracket indicate the studies for which the association was statistically different ( P <0.05). 
 b AR: The absolute risk of PN (or APN) for subjects with a certain distal fi nding (i.e., normal, HP, AD, or AN) was defi ned as the proportion of subjects with PN (or APN) 
and this distal fi nding out of the total number of subjects with that distal fi ndings. OR: the odds ratio refers to the number of subjects with PN (or APN) in the group of 
subjects with distal lesions compared with the number of subjects with PN (or APN) in the reference group (normal distal fi nding). 
 c All  P values are from comparisons between different distal lesions and PN/APN, compared with normal distal fi ndings. 
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neoplasia and multiple non-AN. Hence, the association between 
proximal and distal lesions might be diff erent when serrated 
lesions were included as they were considered as markers of more 
advanced colonic lesions ( 52 ). In addition, the defi nition of “dis-
tal” was also found to modify the association between APN and 
distal AN. Lesions detected in the descending colon and splenic 
fl exure may represent more advanced serrated lesion and possibly 
serrated polyposis syndrome, in which multiple serrated and HPs 
were detected in the whole colon. Furthermore, analyses including 
studies with FS followed by a subsequent colonoscopy as a sepa-
rate procedure (vs. colonoscopy alone) generated weaker associa-
tions between proximal and distal lesions. Th is observation might 
be attributed to the diff erences in bowel preparation, endoscopic 
procedural factors, and the possible involvement of two or more 
endoscopists for the former group. As these subgroup analyses 
included small number of studies and sample size, future evalua-
tion of these associations by larger-scale studies is required.
 Our meta-analysis has a number of strengths. First, it included 
asymptomatic, average-risk subjects in all selected studies. Hence, 
the application of its fi ndings is more generalizable to screening 
practices when compared with previous meta-analyses. Also, it is 
the most updated meta-analysis with the largest number of screen-
ing participants included from all published studies. In addition, 
various moderators of the association between proximal and dis-
tal fi ndings were addressed in subgroup analyses. We performed a 
quality assessment based on an internationally recognized New-
castle Ottawa Scale scale for all the selected articles in a systematic 
manner. Nevertheless, some limitations should be mentioned. For 
instance, publication bias might exist and we could have missed 
some gray literature or informal reports. In addition, the bowel 
preparation quality and adenoma detection rate, as well as the 
qualifi cation and experience of endoscopists involved in the FS 
and colonoscopy procedures, might be diff erent, while most of 
the studies performed colonoscopy to simulate a procedure where 
FS was followed by colonoscopy. Even though patients might 
not have a risk of PN detected if the colonoscopy was performed 
at around the same time as the FS, there could be a risk of PN 
when the patients receive colonoscopy at a signifi cantly later 
time period. Also, larger and more numerous distal HPs could 
potentially indicate higher risk, such as the presence of serrated 
 Figure 3 .  Forest plots of the association between distal fi ndings (hyperplstic polyp (HP), adenoma (AD), advanced neoplasia (AN)) and PN/APN 
comparing with normal distal fi ndings (Random-Effect). ( a ) Odds of proximal neoplasia (PN). ( b ) Odds of advanced proximal neoplasia (APN). CI, 
confi dence interval.
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people of diff erent ethnicities, yet the present studies recruited 
subjects from America, Europe, and Asia only. Th e heterogeneity 
of the study fi ndings could be partly accounted for by the pooled 
ORs from screening participants of diff erent ethnicities.
polyposis syndrome; yet none of the primary studies consisted 
of data on the size and number of distal HPs nor the diff erent 
subtypes of serrated lesions. Finally, it is well recognized that 
the prevalence and distribution of colorectal neoplasia varied in 
Figure 3. Continued.
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1.69 [0.76, 3.76]
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1.29 [0.51, 1.92]
1.03 [0.55, 1.92]
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0.55 [0.16, 1.94]
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1.32 [0.53, 3.30]
10.07 [3.02, 33.64]
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2.99 [1.59, 5.63]
2.07 [0.92, 4.68]
2.46 [1.01, 6.00]
2.78 [1.39, 5.58]
1.86 [0.75, 4.64]
3.25 [2.13, 4.94]
0.89 [0.60, 1.33]
2.50 [1.56, 4.01]
9.89 [5.76, 16.98]
2.52 [1.84, 3.46]
13.16 [4.37, 39.61]
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11.18 [3.33, 37.48]
19.42 [9.09, 41.51]
8.11 [1.32, 49.83]
8.35 [3.28, 21.23]
8.32 [4.20, 16.51]
3.58 [2.12, 6.04]
1.71 [1.06, 2.77]
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6.58 [2.16, 20.06]
2.59 [1.66, 4.05]
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2.82 [2.21, 3.60]
207
38
19
538
300
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464
225
316
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29190 39.8%
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1.1%
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2.3%
2.5%
2.5%
1.4%
1.5%
2.1%
1.6%
1.8%
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2.3%
1.6%
2.5%
10461
564 441
Total events 1134 1169
Study or subgroup
Distal finding
Events Total Events Total Weight
Distal normal Odds ratio
M-H, random, 95% Cl
Odds ratio
M-H, random, 95% Cl
0.01 0.1 1 10 100
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 Table 4 .  Subgroup analysis according to study characteristics 
 Study characteristics   HP  AD  AN 
   N  OR (95%CI)  P  value a  N  OR (95%CI)  P  value a  N  OR (95%CI)  P  value a 
 Study quality (NOS scale) 
 High (4–7)  PN  2  1.08 (0.67–1.73) b  0.45  4  1.96 (1.49–2.57) b  0.09  4  2.13 (1.75–2.58)  <0.001 
 Low (1–3)   4  1.36 (0.93–2.00)   6  2.78 (2.05–3.77) b   3  4.82 (3.35–6.93)  
 High (4–7)  APN  9  1.05 (0.83–1.31)  0.68  13  2.47 (1.68–3.63) b  0.86  14  4.80 (3.21–7.18) b  0.09 
 Low (1–3)   4  1.28 (0.50–3.30)   5  2.63 (1.54–4.48)   5  8.90 (5.29–14.96)  
 Sample size (in total) 
 >3,000  PN  2  1.08 (0.67–1.73) b  0.45  5  2.03 (1.60–2.56) b  0 . 05  4  3.24 (1.85–5.69) b  0.29 
 ≤3,000   4  1.36 (0.93–2.00)   5  3.20 (2.17–4.74)   3  2.30 (1.72–3.09)  
 >3,000  APN  8  1.18 (0.90–1.54)  0.22  11  2.21 (1.62–3.02) b  0.35  13  5.69 (3.37–8.58) b  0.93 
 ≤3,000   5  0.73 (0.36–1.49)   7  3.23 (1.56–6.70) b   6  5.94 (2.33–15.17) b  
 Population-based study design 
 Yes  PN  2  1.08 (0.67–1.73) b  0.45  2  1.88 (1.15–3.06) b  0.26  1  1.94 (1.48–2.54)  0 . 03 
 No   4  1.36 (0.93–2.00)   8  2.57 (2.02–3.26) b   6  3.28 (2.22–4.87) b  
 Yes  APN  1  0.73 (0.48–1.13)  0 . 05  1  0.89 (0.60–1.33)  <0 . 001  3  3.06 (2.31–4.06)  0 . 005 
 No   12  1.22 (0.96–1.55)   17  2.74 (2.08–3.61) b   16  6.73 (4.23–10.70) b  
 Endoscopy quality control 
 Yes  PN  2  1.08 (0.67–1.73) b  0.45  3  1.91 (1.33–2.76) b  0.15  2  2.04 (1.66–2.50)  <0 . 001 
 No   4  1.36 (0.93–2.00)   7  2.66 (2.04–3.47) b   5  4.09 (3.03–5.53)  
 Yes  APN  2  0.93 (0.55–1.58) b  0.39  4  2.20 (0.73–6.61) b  0.75  5  2.59 (1.96–3.41)  <0 . 001 
 No   11  1.21 (0.92–1.58)   15  2.64 (2.18–3.20)   14  8.93 (5.66–11.84) b  
 Defi nition of AN 
 No SL  PN  4  1.16 (0.82–1.62)  NA  9  2.31 (1.86–2.88) b  NA  6  2.96 (2.07–4.25)  NA 
 Include SL   0  —   0  —   0  —  
 No SL  APN  12  1.08 (0.83–1.39)  0.61  17  2.53 (1.79–3.56) b  0.97  17  6.17 (4.00–9.53)  0.070 
 Include SL   1  1.26 (0.72–2.21)   1  2.50 (1.56–4.01)   2  3.55 (2.34–5.39) b  
 Defi nition of “distal” 
 Splenic fl exure  PN  5  1.16 (0.87–1.56)  0.93  9  2.41 (1.92–3.02) b  0.50  6  3.17 (2.00–5.03)  0.19 
 Rectosigmoid   1  1.23 (0.35–4.40)   1  2.02 (1.26–3.22)   1  2.18 (1.58–3.00)  
 Splenic fl exure  APN  13  1.09 (0.87–1.36)  NA  17  2.66 (1.92–3.66) b  0.02  18  6.22 (4.37–8.86) b  <0.001 
 Rectosigmoid   0  —   1  1.05 (0.50–2.20)   1  2.12 (1.41–3.19)  
 Procedure 
 CLN  PN  5  1.37 (1.10–1.71)  0.004  8  2.57 (2.10–3.14) b  0.008  5  4.09 (3.03–5.53)  <0.001 
 FS+CLN   1  0.85 (0.66–1.08)   2  1.60 (1.20–2.13)   2  2.04 (1.66–2.50)  
 CLN  APN  12  1.22 (0.96–1.55)  0.05  16  2.92 (2.24–3.80) b  <0.001  17  6.73 (4.74–9.55) b  <0.001 
 FS+CLN   1  0.73 (0.48–1.13)   2  0.93 (0.65–1.32)   2  2.12 (1.41–3.19)  
 AD, adenoma; AN, advanced neoplasia; APN, advanced proximal neoplasia; CI, confi dential interval; CLN, colonoscopy; FS, fl exible sigmoidoscopy; HP, hyperplastic 
polyp, NOS, Newcastle Ottawa Scale; OR, odds ratio; PN, proximal neoplasia; SL, serrated lesions. If   p  < 0.05, the difference between the two subgroups is statistically 
signifi cant. 
 a P values refer to the Cochran tests for differences between subgroups. 
 b P <0.05 in heterogeneity test. 
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 In conclusion, distal HP is neither a marker for PN nor APN 
in asymptomatic screening population when compared with nor-
mal distal fi ndings. Th e ORs of AD and distal AN for PN/APN 
were signifi cantly increased. Th ese fi ndings did not support rou-
tine referral of all subjects detected having distal HPs. We antici-
pate that this clinical implication has a substantial potential to 
reduce unnecessary colonoscopy procedure, complications, and 
health-care costs. Future prospective studies employing popula-
tion-based design including screening participants of diff erent 
ethnicities screened by good quality-control endoscopies could 
shed more light on the relationship between distal and proximal 
fi ndings.
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 Study Highlights
 WHAT IS CURRENT KNOWLEDGE 
 ✓  Flexible sigmoidoscopy (FS) becomes more popular as a 
primary screening test for colorectal cancer (CRC) screen-
ing in some European and Asian countries. 
 ✓  FS is a recommended test of choice designed both to 
detect and prevent CRC if colonoscopy is not available or 
acceptable to patients. 
 ✓  Whether subjects with distal hyperplastic polyps (HPs) 
detected should be followed up by colonoscopy workup 
remains controversial. 
 WHAT IS NEW HERE 
 ✓  A meta-analysis including 28 studies that included 
104,961 average-risk asymptomatic participants for 
colorectal cancer screening was conducted. 
 ✓  When compared with normal distal fi ndings, distal HP was 
not associated with proximal neoplasia (PN) or advanced 
proximal neoplasia (APN). 
 ✓  Subjects with distal non-advanced or advanced adenoma 
had higher odds of PN/APN, and higher odds of PN/APN 
were observed for more severe distal lesions. 
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